Is it safe to prescribe benzodiazepines (Benzodiazepines) to a patient with a history of substance abuse and an anxiety disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prescribing Benzodiazepines for Patients with History of Substance Abuse and Anxiety Disorders

Benzodiazepines should generally be avoided in patients with a history of substance abuse, even if they have an anxiety disorder that responds to these medications, due to the high risk of dependence, addiction, and potential for misuse.

Risk Assessment Framework

When considering benzodiazepine therapy for patients with both anxiety disorders and substance abuse history, a careful risk-benefit analysis is essential:

High-Risk Factors

  • Active substance use disorder
  • Polysubstance abuse (especially with opioids)
  • Prior benzodiazepine misuse
  • Severe liver disease
  • Respiratory issues
  • History of seizures

Risk Stratification Process

  1. Evaluate substance use history:

    • Duration since last substance use
    • Type of substances previously abused
    • Treatment history and recovery status
    • Current abstinence verification
  2. Assess anxiety disorder:

    • Severity of symptoms
    • Impact on functioning
    • Previous treatment responses
    • Alternative treatment options tried

Evidence-Based Recommendations

The 2017 HIVMA/IDSA clinical practice guideline clearly states that "a patient's history of addiction or substance use disorder is not an absolute contraindication to receiving controlled substances for the management of chronic pain" 1. This principle can be extended to anxiety management, but requires careful risk stratification.

For Lower-Risk Patients:

If benzodiazepines are considered necessary after exhausting alternatives:

  • Use the lowest effective dose for the shortest duration possible 2
  • Implement a structured monitoring program with:
    • Regular face-to-face visits
    • Urine drug screening
    • Prescription monitoring program checks
    • Clear treatment agreements

For Higher-Risk Patients:

When risks outweigh benefits:

  • Utilize non-benzodiazepine anxiety treatments:
    • SSRIs/SNRIs for long-term anxiety management
    • Buspirone for generalized anxiety
    • Hydroxyzine for acute anxiety
    • Pregabalin/gabapentin (with caution)
    • CBT and other psychotherapeutic approaches

Tapering Considerations

If a patient with substance abuse history is already taking benzodiazepines:

  • Develop a structured tapering plan:
    • Reduce dose by 10% of original dose per week as starting point 3
    • For long-term users, slower tapers (10% per month) are better tolerated 3
    • Monitor closely for withdrawal symptoms
    • Consider adjunctive medications to manage withdrawal symptoms

Special Considerations

Concurrent Opioid Use

FDA black box warnings highlight that "concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death" 2. This combination should be strictly avoided in patients with substance abuse history.

Elderly Patients

The 2019 AGS Beers Criteria recommends avoiding benzodiazepines in older adults due to increased sensitivity and risk of cognitive impairment, delirium, falls, fractures, and motor vehicle accidents 1.

Monitoring Requirements

For patients where benzodiazepines are deemed necessary despite history:

  • Weekly contact during active treatment 3
  • Regular assessment for signs of misuse, tolerance, or dose escalation
  • Consider referral for substance use evaluation

Common Pitfalls to Avoid

  1. Indefinite prescribing: Benzodiazepines should be prescribed for the shortest possible duration with a clear exit strategy.

  2. Inadequate monitoring: Patients with substance abuse history require more frequent monitoring than the general population.

  3. Overlooking alternatives: Non-benzodiazepine treatments should be exhausted before considering benzodiazepines.

  4. Ignoring warning signs: Early signs of misuse or diversion should prompt immediate reevaluation of the treatment plan.

  5. Abrupt discontinuation: Always taper benzodiazepines to avoid withdrawal symptoms, which can be life-threatening 2.

While some older research suggests benzodiazepines may be appropriate for certain patients with past substance abuse 4, more recent evidence and guidelines emphasize the substantial risks. The potential for dependence, abuse, and addiction makes benzodiazepines particularly problematic in this vulnerable population, and alternative treatments should be strongly preferred.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Tapering Benzodiazepines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.